Evidence map›Paper›PMID 27276012›Full record

ArticlePloS one2016

Penta-EF-Hand Protein Peflin Is a Negative Regulator of ER-To-Golgi Transport.

Mariah Rayl, Mishana Truitt, Aaron Held, John Sargeant, Kevin Thorsen, Jesse C Hay

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. A pooled image-based CRISPR screen identifies EAF1 as abioRxiv : the preprint server for biology · 2026
    Article
  2. Inter-Organellar CaCells · 2025
    Review
  3. Article
  4. Article
  5. CaFaculty reviews · 2022
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Multifaceted Roles of ALG-2 in Ca(2+)-Regulated Membrane Trafficking.International journal of molecular sciences · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Mariah RaylDivision of Biological Sciences and Center for Structural and Functional Neuroscience, The University of Montana, Missoula, MT, United States of America.
Mishana TruittDivision of Biological Sciences and Center for Structural and Functional Neuroscience, The University of Montana, Missoula, MT, United States of America.
Aaron HeldDivision of Biological Sciences and Center for Structural and Functional Neuroscience, The University of Montana, Missoula, MT, United States of America.
John SargeantDivision of Biological Sciences and Center for Structural and Functional Neuroscience, The University of Montana, Missoula, MT, United States of America.
Kevin ThorsenDivision of Biological Sciences and Center for Structural and Functional Neuroscience, The University of Montana, Missoula, MT, United States of America.
Jesse C HayDivision of Biological Sciences and Center for Structural and Functional Neuroscience, The University of Montana, Missoula, MT, United States of America.
University of Montana · US

Funding

Regulation of ER to Golgi Transport byLuminal CalciumR15GM106323 · NIGMS · UNIVERSITY OF MONTANA · PI HAY, JESSE C · 2013 to 2022
$1.3M
NIGMS NIH HHS R15 GM106323
6 · The paper itself

Abstract

Luminal calcium regulates vesicle transport early in the secretory pathway. In ER-to-Golgi transport, depletion of luminal calcium leads to significantly reduced transport and a buildup of budding and newly budded COPII vesicles and vesicle proteins. Effects of luminal calcium on transport may be mediated by cytoplasmic calcium sensors near ER exits sites (ERES). The penta-EF-hand (PEF) protein apoptosis-linked gene 2 (ALG-2) stabilizes sec31A at ER exit sites (ERES) and promotes the assembly of inner and outer shell COPII components. However, in vitro and intact cell approaches have not determined whether ALG-2 is a negative or positive regulator, or a regulator at all, under basal physiological conditions. ALG-2 interacts with another PEF protein, peflin, to form cytosolic heterodimers that dissociate in response to calcium. However, a biological function for peflin has not been demonstrated and whether peflin and the ALG-2/peflin interaction modulates transport has not been investigated. Using an intact, single cell, morphological assay for ER-to-Golgi transport in normal rat kidney (NRK) cells, we found that depletion of peflin using siRNA resulted in significantly faster transport of the membrane cargo VSV-G. Double depletion of peflin and ALG-2 blocked the increased transport resulting from peflin depletion, demonstrating a role for ALG-2 in the increased transport. Furthermore, peflin depletion caused increased targeting of ALG-2 to ERES and increased ALG-2/sec31A interactions, suggesting that peflin may normally inhibit transport by preventing ALG-2/sec31A interactions. This work identifies for the first time a clear steady state role for a PEF protein in ER-to-Golgi transport-peflin is a negative regulator of transport.

Indexed as

AnimalsApoptosis Regulatory ProteinsBiological Transport, ActiveCalcium-Binding ProteinsCHO CellsCOP-Coated VesiclesCricetinaeCricetulusEndoplasmic ReticulumGolgi ApparatusHumansRatsApoptosis Regulatory ProteinsCalcium-Binding ProteinsPDCD6 protein, humanPEF1 protein, human

Identifiers

PMID27276012
PMCPMC4898701
OpenAlexW2415134854

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.